Search
for
Sort by
Research 121–150 of 1000+
- Cyclosporine A stimulated hair growth from mouse vibrissae follicles in an organ culture model
- Preparation and Evaluation of Topical Formulation of Diphenylcyclopropenone for the Treatment of Alopecia Areata
- Topical Delivery of Protein and Peptide Using Novel Cell Penetrating Peptide IMT-P8
- Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
- A Murine Model for Inducing and Manipulating Hair Follicle Regression (Catagen): Effects of Dexamethasone and Cyclosporin A
- Role of skin enzymes in metabolism of topical drugs
- Effects of Topical application of Astragalus membranaceus in Spontaneous Alopecia Mice Model
- Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- Comparison of autologous platelet concentrates and topical steroids on oral lichen planus: a systematic review and meta-analysis
- Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Fractional CO₂ laser combined with topical compound betamethasone for Vitiligo-Associated Leukotrichia: a retrospective study of 13 patients with limited effectiveness
- Preparation and evaluation of minoxidil nanoemulgel topical formulations.
- Factors Affecting the Response and Patient Satisfaction of Topical Immunotherapy in Alopecia Areata: A Nationwide Study
- Topical effect of a specific spot-on treatment made of natural ingredients in rabbits (Oryctolagus cuniculus) with skin problems: A pilot study
- Three cases of immune‐mediated adnexal skin disease treated with cyclosporin
- Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles
- Re-Evaluating Cyclosporine A as a Hair Growth–Promoting Agent in Human Scalp Hair Follicles
- Enhanced Topical Delivery of Finasteride Using Glyceryl Monooleate-Based Liquid Crystalline Nanoparticles Stabilized by Cremophor Surfactants
- Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Utility of azathioprine, methotrexate and cyclosporine as steroid‐sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients
- A comparative study on therapeutic efficacy between topical dinitrochlorobenzene and topical betamethasone in alopecia areata
- Structural characterization of cyclosporin A, C and microbial bio-transformed cyclosporin A analog AM6 using HPLC–ESI–ion trap-mass spectrometry
- Development of Stratum Corneum Lipid Liposomes for Topical Drug Delivery
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata